Talking Medicines Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
39
- Latest Deal Type
-
Debt Refin.
- Latest Deal Amount
-
$365K
- Investors
-
5
Talking Medicines General Information
Description
Developer of a healthcare technology tool designed to capture, curate, and structure the voice of the patient on launched medicines. The company's platform uses a collection of artificial intelligence, machine learning, and neuro-linguistic programming technological tools to capture and analyze the conversations and behaviors of patients at home and map the patient voice to regulate medicine information and build data points to deliver trends and patterns of usage across medicines and brands, enabling pharmaceutical companies to identify patterns of data across multiple medicines and their therapeutic areas of interest.
Contact Information
Website
www.talkingmedicines.comCorporate Office
- BECO Building
- 58 Kingston Street
- Glasgow G5 8BP
- Scotland, United Kingdom
Corporate Office
- BECO Building
- 58 Kingston Street
- Glasgow G5 8BP
- Scotland, United Kingdom
Talking Medicines Timeline
Talking Medicines Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Debt Refinancing | 26-May-2026 | $365K | Completed | Generating Revenue | ||
| 9. Debt - General | Completed | Generating Revenue | ||||
| 8. Debt Refinancing | 12-Dec-2025 | Completed | Generating Revenue | |||
| 7. Later Stage VC | 05-Dec-2023 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series A) | 31-Jan-2022 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 04-Nov-2020 | Completed | Generating Revenue | |||
| 4. Seed Round | 10-May-2019 | Completed | Generating Revenue | |||
| 3. Seed Round | 16-Jun-2018 | Completed | Generating Revenue | |||
| 2. Seed Round | 28-Aug-2017 | $171K | $171K | Completed | Generating Revenue | |
| 1. Grant | $125K | Completed | Startup |
Talking Medicines Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Series A | ||||||||
| Ordinary | 61,694 | $0.001000 | $13.91 | $13.91 | 1x | $13.91 | 16.24% | |
| Ordinary | 9,826 | $0.001000 | $13.43 | $13.43 | 1x | $13.43 | 2.59% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Talking Medicines Comparisons
Industry
Financing
Details
Talking Medicines Competitors (1)
One of Talking Medicines’s competitors is Brandwatch, a Private Equity-Backed company based in London, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Brandwatch | Private Equity-Backed | London, United Kingdom |
Talking Medicines Patents
Talking Medicines Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202316695-D0 | Method and apparatus for identifying patterns in interactions with medicines | Inactive | 31-Oct-2023 | ||
| WO-2025093878-A1 | Method and apparatus for identifying patterns in interactions with medicines | Inactive | 31-Oct-2023 | ||
| GB-202101783-D0 | Medicine evaluation system | Inactive | 09-Feb-2021 | ||
| US-20240120114-A1 | Medicine evaluation system | Pending | 09-Feb-2021 | ||
| WO-2022171996-A1 | Medicine evaluation system | Inactive | 09-Feb-2021 | G06F16/3344 |
Talking Medicines Signals
Talking Medicines Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Angel (individual) | Minority | |||
| Tern (Private Equity) | Venture Capital | Minority | ||
| Scottish Enterprise | Growth/Expansion | Minority | ||
| SIS Ventures | Impact Investing | Minority | ||
| The Scottish National Investment Bank | Investment Bank | Minority |
Talking Medicines FAQs
-
When was Talking Medicines founded?
Talking Medicines was founded in 2013.
-
Where is Talking Medicines headquartered?
Talking Medicines is headquartered in Glasgow, United Kingdom.
-
What is the size of Talking Medicines?
Talking Medicines has 39 total employees.
-
What industry is Talking Medicines in?
Talking Medicines’s primary industry is Other Healthcare Technology Systems.
-
Is Talking Medicines a private or public company?
Talking Medicines is a Private company.
-
What is Talking Medicines’s current revenue?
The current revenue for Talking Medicines is .
-
How much funding has Talking Medicines raised over time?
Talking Medicines has raised $6.46M.
-
Who are Talking Medicines’s investors?
, Tern (Private Equity), Scottish Enterprise, SIS Ventures, and The Scottish National Investment Bank have invested in Talking Medicines.
-
Who are Talking Medicines’s competitors?
Brandwatch is a competitor of Talking Medicines.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process